ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 7 of 308 for:    complementary and alternative medicine

Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01419210
Recruitment Status : Completed
First Posted : August 18, 2011
Last Update Posted : September 24, 2015
Sponsor:
Collaborator:
University of South Florida
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

August 16, 2011
August 18, 2011
September 24, 2015
January 2010
April 2014   (Final data collection date for primary outcome measure)
Number of Participants Interested in Complementary and Alternative Medicines (CAM) [ Time Frame: Average of 18 Weeks ]
Aim 1, proportions of participants who attend the education sessions (with 95% confidence intervals) will be calculated for each of the 5 CAM therapies. Mean (along with SD) score will be calculated for each therapy.
Same as current
Complete list of historical versions of study NCT01419210 on ClinicalTrials.gov Archive Site
  • Contingency Table [ Time Frame: Average of 18 Weeks ]
    Aim 2, contingency table will be provided to associate pretest factors (e.g., demographics, clinical history, disease status, and psychological status) with the dichotomous outcome of CAM choice.
  • Number of Participants Reporting They Were Influenced by the Education Sessions [ Time Frame: Average of 18 Weeks ]
    Aim 3, symptom experience, quality of life, and knowledge of CAM therapies will be measured pre- and post- CAM education programs. Pre-test means, post-test means, and pre-post difference score means, along with standard deviations, will be calculated. No formal power analysis is planned because this is a pilot study to collect preliminary information for future larger studies.
Same as current
Not Provided
Not Provided
 
Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer
A Pilot Program to Personalize Care by Integrating Traditional and Complementary Medicine for Women With Ovarian Cancer
The purpose of this study is to find out if complementary and alternative medicines (CAM) should be included with traditional therapy for women with ovarian cancer. Some of the alternative medicines include non-traditional drug and herbal therapies along with dietary and nutritional strategies. Only a few of these alternative medicines have been tested with women with ovarian cancer.

The study will be offered to women with ovarian cancer who are receiving care at the Gynecologic Oncology Clinic at H. Lee Moffitt Cancer Center. Prospective candidates, identified via chart review, will receive a mailing that describes and invites them to be screened for eligibility. Potential participants seen in the clinic will also be approached and invited to participate.

The informed consent process and pretesting will take place in the clinic, with exceptions made as needed for women who prefer to complete documents at home.

The intervention, which will consist of four educational CAM sessions, will be held on site in a private room at Moffitt Cancer Center. Immediately before and after each session, we will administer a brief on-site pre- and post-test. Upon completion of the intervention, participants will be asked to complete a post-test on site or at home, depending on their preference. Follow-up telephone calls will be made to the participants at 8 weeks after the last session.

Pre- and post-test measures will focus on quality of life, prior use of CAM therapies, topic preferences, knowledge gained from the presentations, changed intentions and behaviors associated with CAM, and satisfaction with the program.

Interventional
Not Applicable
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Ovarian Cancer
  • Other: Pre-study Questionnaire
    Assess the interest level for various CAM topics through feedback received from the study participants
  • Other: Educational Presentations
    Attend a two-hour presentation each week for four weeks
  • Other: CAM Therapies
    Integrate the CAM topics of highest interest into participant's regular care
  • Other: Post-study Questionnaire
    Examine the data to see if it supports recommending a larger, multi-site, integrative CAM program for other women with ovarian cancer
Experimental: Complementary and Alternative Medicine (CAM) therapies
This pilot program attends to the need for appropriate patient-centered interventions that integrate CAM with traditional care to maximize both quantity and QOL for women with ovarian cancer.
Interventions:
  • Other: Pre-study Questionnaire
  • Other: Educational Presentations
  • Other: CAM Therapies
  • Other: Post-study Questionnaire
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
28
20
September 2015
April 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • A diagnosis of ovarian cancer
  • An Eastern Cooperative Oncology Group (ECOG) score of 2 or less with a life expectancy of at least 12 months
  • A patient being treated by a gynecologic oncologist in the Center for Women's Oncology
  • Ability to read, understand, and sign the informed consent form
  • Ability to read, write and understand English, which will be the language used in the materials and oral presentations
  • Willingness to complete pre-test and post-test questionnaires
  • Willingness to complete brief questionnaires at each session
  • Willingness to participate in one follow-up telephone interview at 8 weeks after the final session
  • Willingness to participate in four sessions that take place at Moffitt Cancer Center
  • Access to transportation, with the ability to travel to and from Moffitt to participate in the sessions
Sexes Eligible for Study: Female
18 Years and older   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01419210
MCC-15221
No
Not Provided
Not Provided
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida
Principal Investigator: Robert Wenham, M.D. H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
September 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP